These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


837 related items for PubMed ID: 11568809

  • 1. Immunoglobulin A anti-beta2-glycoprotein antibodies in women who experience unexplained recurrent spontaneous abortion and unexplained fetal death.
    Lee RM, Branch DW, Silver RM.
    Am J Obstet Gynecol; 2001 Sep; 185(3):748-53. PubMed ID: 11568809
    [Abstract] [Full Text] [Related]

  • 2. Anti-beta2-glycoprotein I antibodies in women with recurrent spontaneous abortion, unexplained fetal death, and antiphospholipid syndrome.
    Lee RM, Emlen W, Scott JR, Branch DW, Silver RM.
    Am J Obstet Gynecol; 1999 Sep; 181(3):642-8. PubMed ID: 10486478
    [Abstract] [Full Text] [Related]

  • 3. Antiphospholipid and antiprotein syndromes in non-thrombotic, non-autoimmune women with unexplained recurrent primary early foetal loss. The Nîmes Obstetricians and Haematologists Study--NOHA.
    Gris JC, Quéré I, Sanmarco M, Boutiere B, Mercier E, Amiral J, Hubert AM, Ripart-Neveu S, Hoffet M, Tailland ML, Rousseau O, Monpeyroux F, Dauzat M, Sampol J, Daures JP, Berlan J, Marès P.
    Thromb Haemost; 2000 Aug; 84(2):228-36. PubMed ID: 10959694
    [Abstract] [Full Text] [Related]

  • 4. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML, Atsumi T, Escudero Contreras A, Khamashta MA, Hughes GR.
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Pathogenic antibodies in women with obstetric features of antiphospholipid syndrome who have negative test results for lupus anticoagulant and anticardiolipin antibodies.
    Silver RM, Pierangeli SS, Edwin SS, Umar F, Harris EN, Scott JR, Branch DW.
    Am J Obstet Gynecol; 1997 Mar; 176(3):628-33. PubMed ID: 9077618
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Relationship between pregnancy loss and antiphospholipid antibody].
    Zhang X, Qian M, Liu S.
    Zhonghua Fu Chan Ke Za Zhi; 1998 Jan; 33(1):10-2. PubMed ID: 10682448
    [Abstract] [Full Text] [Related]

  • 9. Are anti-beta-glycoprotein-I antibodies markers for recurrent pregnancy loss in lupus anticoagulant/anticardiolipin seronegative women?
    Alijotas-Reig J, Casellas-Caro M, Ferrer-Oliveras R, Llurba-Olive E, Hermosilla E, Vilardell-Tarres M, Cabero-Roura L.
    Am J Reprod Immunol; 2008 Sep; 60(3):229-37. PubMed ID: 18782284
    [Abstract] [Full Text] [Related]

  • 10. The detection of anti-beta2-glycoprotein I antibodies is associated with increased risk of pregnancy loss in women with threatened abortion in the first trimester.
    Mezzesimi A, Florio P, Reis FM, D'Aniello G, Sabatini L, Razzi S, Fineschi D, Petraglia F.
    Eur J Obstet Gynecol Reprod Biol; 2007 Aug; 133(2):164-8. PubMed ID: 17046145
    [Abstract] [Full Text] [Related]

  • 11. A case-control study on the association of idiopathic recurrent pregnancy loss with autoantibodies against beta2-glycoprotein I and annexin V.
    Zammiti W, Mtiraoui N, Kallel C, Mercier E, Almawi WY, Mahjoub T.
    Reproduction; 2006 Apr; 131(4):817-22. PubMed ID: 16595732
    [Abstract] [Full Text] [Related]

  • 12. [Antiphospholipid syndrome in females with recurrent fetal losses].
    Krysova LA, Lesniak OM, Putilova NV, Remizova II.
    Klin Med (Mosk); 1999 Apr; 77(7):43-6. PubMed ID: 10483165
    [Abstract] [Full Text] [Related]

  • 13. The investigation on the value of repeat and combination test of ACA and anti-beta2-GPI antibody in women with recurrent spontaneous abortion.
    Bao SH, Wang XP, Lin QD, Di W, Xu L, Ding CW.
    Am J Reprod Immunol; 2008 Oct; 60(4):372-8. PubMed ID: 19046144
    [Abstract] [Full Text] [Related]

  • 14. Association between antiphospholipid antibodies and recurrent fetal loss in women without autoimmune disease: a metaanalysis.
    Opatrny L, David M, Kahn SR, Shrier I, Rey E.
    J Rheumatol; 2006 Nov; 33(11):2214-21. PubMed ID: 17014001
    [Abstract] [Full Text] [Related]

  • 15. Antiphospholipid antibodies in women at risk for preeclampsia.
    Branch DW, Porter TF, Rittenhouse L, Caritis S, Sibai B, Hogg B, Lindheimer MD, Klebanoff M, MacPherson C, VanDorsten JP, Landon M, Paul R, Miodovnik M, Meis P, Thurnau G, National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network.
    Am J Obstet Gynecol; 2001 Apr; 184(5):825-32; discussion 832-4. PubMed ID: 11303189
    [Abstract] [Full Text] [Related]

  • 16. Histologic features of placentas and abortion specimens from women with antiphospholipid and antiphospholipid-like syndromes.
    Van Horn JT, Craven C, Ward K, Branch DW, Silver RM.
    Placenta; 2004 Aug; 25(7):642-8. PubMed ID: 15193871
    [Abstract] [Full Text] [Related]

  • 17. Antiphospholipid antibodies and recurrent abortion.
    Parazzini F, Acaia B, Faden D, Lovotti M, Marelli G, Cortelazzo S.
    Obstet Gynecol; 1991 Jun; 77(6):854-8. PubMed ID: 1903191
    [Abstract] [Full Text] [Related]

  • 18. Unexplained elevations of maternal serum alpha-fetoprotein in women with antiphospholipid antibodies: a harbinger of fetal death.
    Silver RM, Draper ML, Byrne JL, Ashwood EA, Lyon JL, Branch DW.
    Obstet Gynecol; 1994 Jan; 83(1):150-5. PubMed ID: 7505912
    [Abstract] [Full Text] [Related]

  • 19. Thrombophilia and unexplained pregnancy loss in Indian patients.
    Vora S, Shetty S, Salvi V, Satoskar P, Ghosh K.
    Natl Med J India; 2008 Jan; 21(3):116-9. PubMed ID: 19004141
    [Abstract] [Full Text] [Related]

  • 20. Clinical significance of antiphospholipid protein antibodies. Receiver operating characteristics plot analysis.
    Musial J, Swadzba J, Motyl A, Iwaniec T.
    J Rheumatol; 2003 Apr; 30(4):723-30. PubMed ID: 12672190
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 42.